Skip to main content
Log in

The XELOX regime is more convenient and saves time for patients with colorectal cancer

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Conroy T, Hebbar M, Bennouna J, Ducreux M, Ychou M, Llédo G, Adenis A, Faroux R, Rebischung C, Kockler L, Douillard JY.Quality of life of patients with metastatic colorectal cancer receiving either XELOX or FOLFOX-6 regimen: a randomized phase III study. 11th World Congress on Gastrointestinal Cancer: 13 abstr. O-0021, May-Jun 2009. Available from: URL: http://www.worldgicancer.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The XELOX regime is more convenient and saves time for patients with colorectal cancer. Pharmacoecon. Outcomes News 582, 10 (2009). https://doi.org/10.2165/00151234-200905820-00023

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905820-00023

Keywords

Navigation